Study's Care of Acute Pancreatitis at Saint-Etienne University Hospital.
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Sep 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the best way to treat patients with acute pancreatitis, a serious condition where the pancreas becomes inflamed. The study is comparing two different types of hospital care: treatment in general internal medicine wards versus treatment in specialized units focused on digestive diseases. Researchers want to find out which approach leads to better outcomes for patients with this condition.
To be eligible for the trial, participants need to be adults diagnosed with acute pancreatitis and admitted to either internal medicine or gastroenterology departments. If you participate, you can expect to receive standard care while researchers monitor and compare the results from both treatment approaches. The trial is currently recruiting participants of all genders, and it's important to know that your participation could help improve future care for patients with acute pancreatitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patient
- • primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology.
- Exclusion Criteria:
- • -
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Etienne, , France
Patients applied
Trial Officials
Kyria REGALADE, resident
Principal Investigator
CHU SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported